Ductal carcinoma in situ: Treatment or active surveillance?
Expert Review of Anticancer Therapy, ISSN: 1744-8328, Vol: 15, Issue: 7, Page: 777-785
2015
- 20Citations
- 54Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations20
- Citation Indexes20
- 20
- CrossRef14
- Captures54
- Readers54
- 54
- Mentions1
- News Mentions1
- News1
Most Recent News
Why Surgery Isn’t Always Necessary for This Form of Breast Cancer
How could breast cancer treatment be unnecessary? Xray Computer/Shutterstock The thought of a breast cancer diagnosis strikes a chill in the heart of every woman.
Review Description
Ductal carcinoma-in situ (DCIS) is a non-obligate precursor for invasive breast cancer and concern exists regarding the potential for overdiagnosis and overtreatment as the natural history of DCIS progression to invasive breast cancer may never occur or take decades in some cases. Preoperative systemic therapy window studies may provide powerful clues to best uncover which particular DCIS lesions respond to systemic therapies and allow for future selective personalized management recommendations. One of the main challenges for instituting active surveillance for DCIS with vacuum-assisted core needle biopsy alone and no surgery is concern for leaving untreated occult invasive carcinoma. Breast MRI lacks sufficient diagnostic ability to differentiate pure DCIS from invasive cancer with DCIS. Current novel randomized trials investigating active surveillance versus active management are described. Multigene expression assays may someday prove useful in stratifying patients at increased risk for progression to invasive breast cancer in the absence of surgery.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84933506200&origin=inward; http://dx.doi.org/10.1586/14737140.2015.1043897; http://www.ncbi.nlm.nih.gov/pubmed/25938920; http://www.tandfonline.com/doi/full/10.1586/14737140.2015.1043897; http://informahealthcare.com/doi/abs/10.1586/14737140.2015.1043897; http://www.tandfonline.com/doi/abs/10.1586/14737140.2015.1043897
Informa UK Limited
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know